ELMSFORD, N.Y.--(BUSINESS WIRE)--BioScrip (NASDAQ: BIOS) today announced that David W. Froesel, Jr. has been appointed Executive Vice President, Chief Financial Officer and Treasurer effective today. Mr. Froesel will replace Stanley G. Rosenbaum, who will be leaving the Company prior to year-end.
